"Cardiotoxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that have a damaging effect on the HEART. Such damage can occur from ALKYLATING AGENTS; FREE RADICALS; or metabolites from OXIDATIVE STRESS and in some cases is countered by CARDIOTONIC AGENTS. Induction of LONG QT SYNDROME or TORSADES DE POINTES has been the reason for viewing some drugs as cardiotoxins.
| Descriptor ID |
D054715
|
| MeSH Number(s) |
D27.888.569.142
|
| Concept/Terms |
Cardiotoxins- Cardiotoxins
- Cardiotoxic Agents
- Agents, Cardiotoxic
|
Below are MeSH descriptors whose meaning is more general than "Cardiotoxins".
Below are MeSH descriptors whose meaning is more specific than "Cardiotoxins".
This graph shows the total number of publications written about "Cardiotoxins" by people in this website by year, and whether "Cardiotoxins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiotoxins" by people in Profiles.
-
Nicolazzi MA, Carnicelli A, Fuorlo M, Scaldaferri A, Masetti R, Landolfi R, Favuzzi AMR. Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer. Eur Rev Med Pharmacol Sci. 2018 04; 22(7):2175-2185.
-
Pollack PS, Chadwick KD, Smith DM, Billger M, Hirshberg B, Iqbal N, Boulton DW. Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin. Cardiovasc Diabetol. 2017 09 13; 16(1):113.
-
Subzposh F, Gupta A, Hankins SR, Eisen HJ. Management of ACCF/AHA Stage A and B patients. Cardiol Clin. 2014 Feb; 32(1):63-71, viii.
-
Johnson NJ, Gaieski DF, Allen SR, Perrone J, DeRoos F. A review of emergency cardiopulmonary bypass for severe poisoning by cardiotoxic drugs. J Med Toxicol. 2013 Mar; 9(1):54-60.
-
Abu-Khalaf MM, Bader F. Cancer therapy related cardiotoxicity. Curr Cardiol Rev. 2011 Nov; 7(4):213.
-
Cheng H, Kari G, Dicker AP, Rodeck U, Koch WJ, Force T. A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity. Circ Res. 2011 Dec 09; 109(12):1401-9.